SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-001538
Filing Date
2021-02-11
Accepted
2021-02-11 16:38:00
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtgn10q_dec312020.htm 10-Q 2340781
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31 12122
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31 12860
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32.htm EX-32 7154
  Complete submission text file 0001654954-21-001538.txt   5101589

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vtgn-20201231.xml EX-101.INS 694329
6 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20201231.xsd EX-101.SCH 35014
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20201231_cal.xml EX-101.CAL 56704
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20201231_def.xml EX-101.DEF 111847
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20201231_lab.xml EX-101.LAB 222421
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20201231_pre.xml EX-101.PRE 188246
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 21620305
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences